Vote Scores
Filings read through

How funds voted at Benitec Biopharma Inc.

Ticker
BNTC
SEC company number
1808898
Filers reporting
109, year to 30 June 2026
Latest meeting on file
Meetings on file
4

In the year to 30 June 2026, 109 filers on Form N-PX reported votes at Benitec Biopharma Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 195 marks to the ballot items, each with or against management. 54.4% of the marks are with management.

On say-on-pay, 88 of the 107 reporting filers that marked the item voted against management. This is 82.2% of the filers. Of the reported shares, 24.2% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

At the meeting of 1 Dec 2025, 5 fund families have a say-on-pay position with management and 28 have a position against management.

By filers reporting in the year to 30 June 2026, Benitec Biopharma Inc. was number 3,596 of 11,972 companies with a page and votes in that year. The number of filers reporting at Benitec Biopharma Inc. rose by 354.2% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 41.3% of the vote records at Benitec Biopharma Inc.. At all companies on this site, it is 12.3%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 1 Dec 2025

109 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    2 nominees. 91.6% of the reported votes are for. 9 filers withheld from or voted against at least one nominee.

    142 vote records from 44 filers. 1 of the 44 filers that marked the item voted against management.

    • Positions of 25 fund families
    • For 19
    • Abstain or withhold 1
    • Split or no vote 5
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    152 vote records from 109 filers. 88 of the 107 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 33 fund families
    • For 4
    • Against 29
    • Against management 28
  3. Item 3: Audit-related items (auditor ratification)

    71 vote records from 44 filers. 0 of the 44 filers that marked the item voted against management.

    • Positions of 25 fund families
    • For 25

Positions of the fund families at the meeting of 1 Dec 2025

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Benitec Biopharma Inc., meeting of 1 Dec 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
AllianceBernsteinAgainst, against management
AllspringAgainst, against management
BlackRock and iSharesAgainst, against management
BNY MellonAgainst, against management
Brighthouse FundsAgainst
Charles SchwabAgainst, against management
Columbia ThreadneedleAgainst, against management
DWSAgainst, against management
EquitableAgainst, against management
FidelityAgainst, against management
Franklin TempletonFor
Global XAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
InvescoAgainst, against management
J.P. MorganFor
Janus HendersonFor
Lincoln FinancialAgainst, against management
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
NationwideAgainst, against management
Northern Trust and FlexSharesFor
Nuveen and TIAAAgainst, against management
Pacific Life fundsAgainst, against management
PGIM and PrudentialAgainst, against management
PrincipalAgainst, against management
ProShares and ProFundsAgainst, against management
Russell InvestmentsAgainst, against management
SEIAgainst, against management
State Street and SPDRAgainst, against management
T. Rowe PriceAgainst, against management
VanguardAgainst, against management
Victory CapitalAgainst, against management
VoyaAgainst, against management

Every meeting on file

Meetings of Benitec Biopharma Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026109382.2%
year to 30 June 20252340.0%
year to 30 June 202563not reported
year to 30 June 20241940.0%

Say-on-pay, season by season

Say-on-pay at Benitec Biopharma Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202610982.2%24.2%
year to 30 June 2025240.0%0.0%
year to 30 June 2024200.0%0.0%
Benitec Biopharma Inc. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management82.2%6.6%
Reported shares against management24.2%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Benitec Biopharma Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS16433.4%
SECTION 14A SAY-ON-PAY VOTES20341.3%
AUDIT-RELATED8517.3%
CAPITAL STRUCTURE173.5%
COMPENSATION142.9%
CORPORATE GOVERNANCE81.6%

The record at the SEC

Each link loaded on .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Cite this page

Vote Scores. How funds voted at Benitec Biopharma Inc.. https://votescores.com/company/benitec-biopharma-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Benitec Biopharma Inc. are on file?
4 meetings are on file, from 6 Dec 2023 to 1 Dec 2025. 2 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Benitec Biopharma Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Benitec Biopharma Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Benitec Biopharma Inc., grouped by company. The name is the most common spelling among filers. The ticker and the SEC company number come from the SEC company tickers file, matched on the exact name. The filers wrote the filings. Filings read through .